Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity

Journal of Viral Hepatitis

Volumn 15, Issue 6, 2008, Pages 459-470

  Yu, H ^a   Babiuk, L A ^a   Van Drunen Littel Van Den Hurk, S ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Dendritic cell loading; Hepatitis C; NS5a; Vaccination

Indexed keywords

DENDRITIC CELL VACCINE; MESSENGER RNA; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4; NONSTRUCTURAL PROTEIN 5A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC TRANSFECTION; HELPER CELL; HEPATITIS C VIRUS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VACCINATION; VACCINIA VIRUS; VIRUS IMMUNITY;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DNA, VIRAL; HEPACIVIRUS; IMMUNIZATION; MICE; MICE, INBRED BALB C; PLASMIDS; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINIA VIRUS; VIRAL HEPATITIS VACCINES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 43549113865     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.00959.x     Document Type: Article

References (47)

1. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 2000 75 (3 17 28.
2. Curry MP. Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation 2004 78 (7 955 963.
3. Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. Health Technol Assess 2004 8 (39 iii iv, 1 125.
4. Fried MW, Hadziyannis SJ. Treatment of chronic hepatitis C infection with peginterferons plus ribavirin. Semin Liver Dis 2004 24 (Suppl. 2 47 54.
5. Pancholi P, Liu Q, Tricoche N, Zhang P, Perkus ME, Prince AM. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins. J Infect Dis 2000 182 (1 18 27.
6. Esser MT, Marchese RD, Kierstead LS et al. Memory T cells and vaccines. Vaccine 2003 21 (5-6 419 430.
7. Neumann-Haefelin C, Blum HE, Chisari FV, Thimme R. T cell response in hepatitis C virus infection. J Clin Virol 2005 32 (2 75 85.
8. Pawlotsky JM. Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis 2003 7 (1 45 66.
9. Simmonds P. Viral heterogeneity of the hepatitis C virus. J Hepatol 1999 31 (Suppl. 1 54 60.
10. Inchauspe G, Feinstone S. Development of a hepatitis C virus vaccine. Clin Liver Dis 2003 7 (1 243 259, xi.
11. Fournillier A, Dupeyrot P, Martin P et al. Primary and memory T cell responses induced by hepatitis C virus multiepitope long peptides. Vaccine 2006 24 (16 3153 3164.
12. Schulze zur Wiesch J, Lauer GM, Day CL et al. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 2005 175 (6 3603 3613.
13. Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G. Dendritic cells as vectors for therapy. Cell 2001 106 (3 271 274.
14. Cerundolo V, Hermans IF, Salio M. Dendritic cells: a journey from laboratory to clinic. Nat Immunol 2004 5 (1 7 10.
15. Pouniotis DS, Proudfoot O, Bogdanoska V, Apostolopoulos V, Fifis T, Plebanski M. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect. Infect Immun 2004 72 (9 5331 5339.
16. Brown K, Gao W, Alber S et al. Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys. J Immunol 2003 171 (12 6875 6882.
17. d'Ostiani CF, Del Sero G, Bacci A et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 2000 191 (10 1661 1674.
18. Berberich C, Ramirez-Pineda JR, Hambrecht C, Alber G, Skeiky YA, Moll H. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. J Immunol 2003 170 (6 3171 3179.
19. Ramirez-Pineda JR, Frohlich A, Berberich C, Moll H. Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC. J Immunol 2004 172 (10 6281 6289.
20. Yu H, Babiuk LA, van Drunen Littel-van den Hurk S. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA. Vaccine 2007 25 (10 1701 1711.
21. Racanelli V, Behrens SE, Aliberti J, Rehermann B. Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity. Immunity 2004 20 (1 47 58.
22. Matsui M, Moriya O, Abdel-Aziz N, Matsuura Y, Miyamura T, Akatsuka T. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus. Vaccine 2002 21 (3-4 211 220.
23. Encke J, Findeklee J, Geib J, Pfaff E, Stremmel W. Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection. Clin Exp Immunol 2005 142 (2 362 369.
24. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL. Viral subversion of the immune system. Annu Rev Immunol 2000 18 : 861 926.
25. Jenne L, Hauser C, Arrighi JF, Saurat JH, Hugin AW. Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther 2000 7 (18 1575 1583.
26. Drillien R, Spehner D, Bohbot A, Hanau D. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 2000 268 (2 471 481.
27. Kruse M, Rosorius O, Kratzer F et al. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol 2000 74 (15 7127 7136.
28. Salio M, Cella M, Suter M, Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 1999 29 (10 3245 3253.
29. Engelmayer J, Larsson M, Subklewe M et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Immunol 1999 163 (12 6762 6768.
30. Pontarollo RA, Babiuk LA, Hecker R, Van Drunen Littel-Van Den Hurk S. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J Gen Virol 2002 83 (Pt 12 2973 2981.
31. Van Meirvenne S, Straetman L, Heirman C et al. Efficient genetic modification of murine dendritic cells by electroporation with mRNA. Cancer Gene Ther 2002 9 (9 787 797.
32. Liu Y, Chiriva-Internati M, Grizzi F et al. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther 2001 8 (12 948 957.
33. Nonn M, Schinz M, Zumbach K et al. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7. J Cancer Res Clin Oncol 2003 129 (9 511 520.
34. Bryan LA, Griebel PJ, Haines DM, Davis WC, Allen JR. Immunocytochemical identification of bovine Langerhans cells by use of a monoclonal antibody directed against class II MHC antigens. J Histochem Cytochem 1988 36 (8 991 995.
35. Yu H, Huang H, Xiang J, Babiuk LA, van Drunen Littel-van den Hurk S. Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. J Gen Virol 2006 87 (Pt 1 1 10.
36. Ioannou XP, Griebel P, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J Virol 2002 76 (18 9002 9010.
37. Lewis PJ, van Drunen Littel-van den H, Babiuk LA. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J Virol 1999 73 (12 10214 10223.
38. Baca-Estrada ME, Snider M, Tikoo SK, Harland R, Babiuk LA, van Drunen Littel-van den Hurk S. Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses. Viral Immunol 1996 9 (1 11 22.
39. Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ, Liang TJ. Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Acad Sci USA 2003 100 (11 6753 6758.
40. Pancholi P, Perkus M, Tricoche N, Liu Q, Prince AM. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice. J Virol 2003 77 (1 382 390.
41. Grunebach F, Muller MR, Nencioni A, Brossart P. Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes. Gene Ther 2003 10 (5 367 374.
42. Gilboa E, Vieweg J. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol Rev 2004 199 : 251 263.
43. Moriya O, Matsui M, Osorio M et al. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein. Vaccine 2001 20 (5-6 789 796.
44. Kuzushita N, Gregory SH, Monti NA, Carlson R, Gehring S, Wands JR. Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens. Gastroenterology 2006 130 (2 453 464.
45. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995 182 (2 389 400.
46. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1999 1 (6 362 368.
47. Santin AD, Hermonat PL, Ravaggi A et al. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. J Virol 1999 73 (7 5402 5410.